Latest News

Ferrari N.V. ( BIT:RACE ) is about to trade ex-dividend in the next four days. The ex-dividend date is two business...

Intercede Group plc ( LON:IGP ), is not the largest company out there, but it saw a double-digit share price rise of...

As European markets rally following a U.S.-Iran ceasefire, the pan-European STOXX Europe 600 Index has seen a notable uptick, reflecting improved investor sentiment amid easing geopolitical tensions. In this evolving landscape, identifying small-cap stocks that are potentially undervalued and have insider buying activity can be an intriguing strategy for those looking to navigate the current market dynamics.

As European markets rally amid a temporary ceasefire between the U.S. and Iran, investor sentiment has improved, leading to gains across major indices such as Germany’s DAX and France’s CAC 40. This positive shift provides a backdrop for exploring opportunities in lesser-known investment areas like penny stocks. Although the term 'penny stock' might sound outdated, it still signifies smaller or newer companies that can offer significant potential returns when backed by strong financials. In...

BW Energy Limited ( OB:BWE ) shareholders will have a reason to smile today, with the analysts making substantial...

When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...

Money Forward, Inc. recently held board meetings to consider introducing a shareholder benefit program and issuing new shares as restricted stock compensation, alongside reporting its Q1 2026 results and hosting an earnings call on April 14, 2026. This combination of governance decisions and earnings disclosure highlights how Money Forward is using both capital allocation tools and investor incentives to shape its shareholder relations approach. Next, we'll examine how the anticipated...

Gold.com (NYSE:GOLD) has acquired Sunshine Minting, Inc., expanding directly into minting and refining. The company has created a new Minting & Refining Division and appointed Jamie Meadows as its CEO. This move marks a shift in Gold.com's operational footprint beyond its existing business lines. For investors watching Gold.com at a share price of $44.51, this acquisition comes after substantial long term share price moves, including a 28.0% return year to date and a 202.8% return over five...

As European markets rally in response to a temporary ceasefire between the U.S. and Iran, investors are eyeing opportunities amidst shifting market dynamics. With the pan-European STOXX Europe 600 Index up over 3% for the week, it's an opportune time to explore lesser-known stocks that may benefit from improved sentiment and resilience against economic uncertainties. In this environment, a good stock often exhibits strong fundamentals, adaptability to changing conditions, and potential for...

As European markets rally following a U.S.-Iran ceasefire, investor sentiment is buoyed by the potential for reduced geopolitical tensions, with major indices like Germany’s DAX and France’s CAC 40 posting notable gains. In this environment of cautious optimism, dividend stocks can offer a compelling blend of income and stability, making them an attractive option for those seeking to navigate current market uncertainties while benefiting from consistent returns.

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see...

Imperial Metals (TSX:III) reported quarterly operating results with ore milled totaling 1,499,749 tonnes, and copper and gold output lower than in the same period last year, a development that can quickly influence how investors assess the stock. See our latest analysis for Imperial Metals. At a share price of CA$8.90, Imperial Metals has seen short term share price strength with a 6.21% 1 day and 13.23% 7 day return, set against a 25.77% 90 day share price decline and a very large 1 year...

In recent days, Fortive has been in focus as investors reassess the company’s aging profit drivers, flat earnings per share over the past five years, and weaker returns on capital amid ongoing end‑market pressures. An interesting angle is how these operational challenges intersect with recent concerns that Fortive’s shares may be trading above intrinsic value while insiders have sold US$400,000 of stock without corresponding purchases. With investor attention on insider selling and business...

Nano Nuclear Energy (NasdaqCM:NNE) has proposed a joint project with Argentina's state-run Dioxitek to develop a uranium hexafluoride production facility. The plan represents Nano Nuclear's first formal project step outside the U.S. and extends its involvement into the nuclear fuel conversion segment. The proposal follows an earlier memorandum between the two parties and moves the relationship toward potential commercial terms, pending Argentinian review. Nano Nuclear Energy has mainly been...

Access MeMed BV approval puts Danaher’s diagnostics in focus Beckman Coulter Diagnostics, part of Danaher (DHR), has received CE 2797 mark approval under the IVDR for its Access MeMed BV assay, a rapid bacterial versus viral infection test delivering results in about 20 minutes. See our latest analysis for Danaher. Despite the positive Diagnostics news, Danaher’s share price has had mixed momentum, with a 6.0% 1 month share price return and a 16.5% 3 month decline, while the 1 year total...

Nestlé S.A. ( VTX:NESN ) stock is about to trade ex-dividend in 4 days. The ex-dividend date is commonly two business...

While Aeffe S.p.A. ( BIT:AEF ) might not have the largest market cap around , it saw a decent share price growth of 17...

As global markets experience a shift in sentiment following the U.S.-Iran ceasefire agreement, investor optimism is on the rise, particularly in regions like Asia where geopolitical tensions have been closely watched. Despite being considered a niche investment area today, penny stocks continue to capture interest due to their potential for growth and value creation within smaller or newer companies. By focusing on those with robust financial health and clear growth prospects, investors can...

As Asian markets navigate the complexities of geopolitical tensions and economic shifts, investor sentiment has been buoyed by recent positive developments such as the U.S.-Iran ceasefire, which has contributed to a more favorable investment climate. In this context, dividend stocks can offer a compelling option for investors seeking stability and income generation amidst fluctuating market conditions.

While Janison Education Group Limited ( ASX:JAN ) might not have the largest market cap around , it saw a decent share...

Stock move puts Phathom Pharmaceuticals in focus Recent trading in Phathom Pharmaceuticals (PHAT) has drawn fresh attention to the gastrointestinal drug developer, with investors weighing its current market value against the ongoing commercialization of VOQUEZNA therapies in the United States. See our latest analysis for Phathom Pharmaceuticals. At a share price of $12.67, recent trading has come after a 22.18% 1 month share price return but follows a 19.35% decline year to date and a 165.62%...

STAAR Surgical Company reported preliminary net sales of over US$90,000,000 for the first quarter ended April 3, 2026, compared with US$42,600,000 a year earlier. This sharp year-on-year increase in quarterly revenue highlights a significant step-change in the company’s recent commercial performance and operating momentum. We’ll now examine how this sharp year-on-year revenue increase could reshape STAAR Surgical’s investment narrative and future business expectations. We've uncovered the 12...

In April 2026, Daiichi Sankyo and Merck reported that the FDA accepted and granted Priority Review to their Biologics License Application for ifinatamab deruxtecan for adults with extensive-stage small cell lung cancer progressing after platinum-based chemotherapy, with an FDA action date set for October 10, 2026. This Priority Review, alongside Breakthrough Therapy Designation and inclusion in programs like Real-Time Oncology Review and Project Orbis, underscores regulatory momentum for...

Wondering if Coupang at around US$20.72 is a bargain or just fairly priced? This article walks through what that number might really mean for you. The stock has returned 8.0% over the last 7 days and 12.3% over the last 30 days, while year to date it is at an 11.3% loss and the 1 year return sits at a 3.5% loss, compared with a 30.6% gain over 3 years and a 51.4% loss over 5 years. Recent headlines around Coupang have focused on its role as a major Korea based e commerce platform and how its...